179 related articles for article (PubMed ID: 16314407)
1. Rapid screening of blood-brain barrier penetration of drugs using the immobilized artificial membrane phosphatidylcholine column chromatography.
Yoon CH; Kim SJ; Shin BS; Lee KC; Yoo SD
J Biomol Screen; 2006 Feb; 11(1):13-20. PubMed ID: 16314407
[TBL] [Abstract][Full Text] [Related]
2. The use of biopartitioning micellar chromatography and immobilized artificial membrane column for in silico and in vitro determination of blood-brain barrier penetration of phenols.
Stępnik KE; Malinowska I
J Chromatogr A; 2013 Apr; 1286():127-36. PubMed ID: 23506703
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of in vitro brain penetration: optimized PAMPA and MDCKII-MDR1 assay comparison.
Carrara S; Reali V; Misiano P; Dondio G; Bigogno C
Int J Pharm; 2007 Dec; 345(1-2):125-33. PubMed ID: 17624703
[TBL] [Abstract][Full Text] [Related]
4. Relationship between immobilized artificial membrane chromatographic retention and human oral absorption of structurally diverse drugs.
Kotecha J; Shah S; Rathod I; Subbaiah G
Int J Pharm; 2007 Mar; 333(1-2):127-35. PubMed ID: 17095172
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of various PAMPA models to identify the most discriminating method for the prediction of BBB permeability.
Mensch J; Melis A; Mackie C; Verreck G; Brewster ME; Augustijns P
Eur J Pharm Biopharm; 2010 Mar; 74(3):495-502. PubMed ID: 20067834
[TBL] [Abstract][Full Text] [Related]
6. Rapidly profiling blood-brain barrier penetration with liposome EKC.
Wang Y; Sun J; Liu H; He Z
Electrophoresis; 2007 Jul; 28(14):2391-5. PubMed ID: 17578839
[TBL] [Abstract][Full Text] [Related]
7. Current in vitro and in silico models of blood-brain barrier penetration: a practical view.
Vastag M; Keseru GM
Curr Opin Drug Discov Devel; 2009 Jan; 12(1):115-24. PubMed ID: 19152220
[TBL] [Abstract][Full Text] [Related]
8. In vitro P-glycoprotein assays to predict the in vivo interactions of P-glycoprotein with drugs in the central nervous system.
Feng B; Mills JB; Davidson RE; Mireles RJ; Janiszewski JS; Troutman MD; de Morais SM
Drug Metab Dispos; 2008 Feb; 36(2):268-75. PubMed ID: 17962372
[TBL] [Abstract][Full Text] [Related]
9. Porcine brain microvessel endothelial cells as an in vitro model to predict in vivo blood-brain barrier permeability.
Zhang Y; Li CS; Ye Y; Johnson K; Poe J; Johnson S; Bobrowski W; Garrido R; Madhu C
Drug Metab Dispos; 2006 Nov; 34(11):1935-43. PubMed ID: 16896068
[TBL] [Abstract][Full Text] [Related]
10. High throughput artificial membrane permeability assay for blood-brain barrier.
Di L; Kerns EH; Fan K; McConnell OJ; Carter GT
Eur J Med Chem; 2003 Mar; 38(3):223-32. PubMed ID: 12667689
[TBL] [Abstract][Full Text] [Related]
11. Prediction of drug bioavailability in humans using immobilized artificial membrane phosphatidylcholine column chromatography and in vitro hepatic metabolic clearance.
Shin BS; Yoon CH; Balthasar JP; Choi BY; Hong SH; Kim HJ; Lee JB; Hwang SW; Yoo SD
Biomed Chromatogr; 2009 Jul; 23(7):764-9. PubMed ID: 19296531
[TBL] [Abstract][Full Text] [Related]
12. Prediction of drug absorption based on immobilized artificial membrane (IAM) chromatography separation and calculated molecular descriptors.
Yen TE; Agatonovic-Kustrin S; Evans AM; Nation RL; Ryand J
J Pharm Biomed Anal; 2005 Jul; 38(3):472-8. PubMed ID: 15890485
[TBL] [Abstract][Full Text] [Related]
13. Ionization-specific QSAR models of blood-brain penetration of drugs.
Lanevskij K; Japertas P; Didziapetris R; Petrauskas A
Chem Biodivers; 2009 Nov; 6(11):2050-4. PubMed ID: 19937840
[TBL] [Abstract][Full Text] [Related]
14. Applications of a blood-brain barrier technology platform to predict CNS penetration of various chemotherapeutic agents. 1. Anti-infective drugs.
Adenot M; Perriere N; Scherrmann JM; Lahana R
Chemotherapy; 2007; 53(1):70-2. PubMed ID: 17202814
[TBL] [Abstract][Full Text] [Related]
15. Diketopiperazines as a tool for the study of transport across the blood-brain barrier (BBB) and their potential use as BBB-shuttles.
Teixidó M; Zurita E; Malakoutikhah M; Tarragó T; Giralt E
J Am Chem Soc; 2007 Sep; 129(38):11802-13. PubMed ID: 17764181
[TBL] [Abstract][Full Text] [Related]
16. Strategies to optimize brain penetration in drug discovery.
Liu X; Chen C
Curr Opin Drug Discov Devel; 2005 Jul; 8(4):505-12. PubMed ID: 16022187
[TBL] [Abstract][Full Text] [Related]
17. [Evaluation of interaction between drugs and ordered phospholipid membrane by immobilized artificial membrane chromatography].
Sun J; Cheng G; He ZG; Wang SJ
Yao Xue Xue Bao; 2003 Sep; 38(9):702-6. PubMed ID: 14730923
[TBL] [Abstract][Full Text] [Related]
18. Toward an improved prediction of human in vivo brain penetration.
Summerfield SG; Lucas AJ; Porter RA; Jeffrey P; Gunn RN; Read KR; Stevens AJ; Metcalf AC; Osuna MC; Kilford PJ; Passchier J; Ruffo AD
Xenobiotica; 2008 Dec; 38(12):1518-35. PubMed ID: 18979396
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of sphingomyelin, cholester, and phosphatidylcholine-based immobilized artificial membrane liquid chromatography to predict drug penetration across the blood-brain barrier.
De Vrieze M; Verzele D; Szucs R; Sandra P; Lynen F
Anal Bioanal Chem; 2014 Oct; 406(25):6179-88. PubMed ID: 25124450
[TBL] [Abstract][Full Text] [Related]
20. Progress in brain penetration evaluation in drug discovery and development.
Liu X; Chen C; Smith BJ
J Pharmacol Exp Ther; 2008 May; 325(2):349-56. PubMed ID: 18203948
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
